[1]
“Perceptions of Medical Practitioner Regarding Adverse Drug Reactions Reporting and Pharmacovigilance”, J Shaheed Suhrawardy Med Coll, vol. 6, no. 1, pp. 18–22, Mar. 2017, doi: 10.3329/jssmc.v6i1.31487.